Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
health database for adults with type 2 diabetes who were treated with either a GLP-1 drug or another type of drug called dipeptidyl peptidase-4 inhibitor (known as DPP-4 inhibitors or gliptins)
Research Results Clinically tested for skin irritation on sensitive Skin Clinically tested for non-comedogenic After a single application, more than 85 % of the skin hydration lasted for up to 24 hours.* *Clinical testing in 20 people
In clinical trials, participants reported an average weight loss of approximately 15% of their body weight over a 72-week period
Unflavoured powder blends smoothly into drinks and recipes
The Oral Small-Molecule GLP-1 Competition Orforglipron isn't the only oral small-molecule GLP-1 agonist in development
